Lite Strategy, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lite Strategy, Inc. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $48.65M.
- Lite Strategy, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $3.14M, a 1872.33% increase year-over-year.
- Lite Strategy, Inc. stock issued during period, value, new issues for the quarter ending 2020-03-31 was -$8.00K.
- Lite Strategy, Inc. stock issued during period, value, new issues for the quarter ending 2019-12-31 was $48.45M.
- Lite Strategy, Inc. stock issued during period, value, new issues for fiscal 2022 was $48.67M, a 1452.07% increase from fiscal 2021.
- Lite Strategy, Inc. stock issued during period, value, new issues for fiscal 2021 was $3.14M, a 95.47% decline from fiscal 2020.
- Lite Strategy, Inc. stock issued during period, value, new issues for fiscal 2020 was $69.23M, a 1171.69% increase from fiscal 2019.
- Lite Strategy, Inc. stock issued during period, value, new issues for fiscal 2019 was $5.44M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-06-30 | $48.67M 10-K · filed 2023-09-26 | |
| 2021-12-31 | $48.65M 10-Q · filed 2023-05-11 | |
| 2021-06-30 | $3.14M 10-K · filed 2022-09-08 | |
| 2020-09-30 | $3.14M 10-Q/A · filed 2022-05-23 | |
| 2020-06-30 | $69.23M 10-K · filed 2022-09-08 | |
| 2020-03-31 | -$8.00K 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $48.45M 10-Q · filed 2021-05-06 | |
| 2019-09-30 | $159.00K 10-Q · filed 2021-05-06 | |
| 2019-06-30 | $5.44M 10-K/A · filed 2022-05-23 | |
| 2018-09-30 | -$324.00K 10-Q · filed 2020-05-07 | |
| 2017-06-30 | $4.21M 10-K · filed 2019-08-28 | |
| 2015-06-30 | $43.07M 10-K · filed 2017-09-05 | |
| 2014-06-30 | $32.70M 10-K · filed 2016-09-06 | |
| 2013-06-30 | $39.45M 10-K · filed 2015-09-02 | |
| 2012-06-30 | $9.83M 10-K · filed 2014-09-09 | |
| 2011-06-30 | $45.00K 10-K · filed 2012-09-18 | |
| 2009-06-30 | $9.77M 10-K · filed 2013-09-18 | |
| 2008-06-30 | $14.73M 10-K · filed 2013-09-18 | |
| 2007-06-30 | $16.82M 10-K · filed 2013-09-18 | |
| 2004-06-30 | $25.58M 10-K · filed 2013-09-18 | |
| 2003-06-30 | $36.00K 10-K · filed 2013-09-18 | |
| 2002-06-30 | $9.02M 10-K · filed 2013-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |